使用18F-FLT和胸苷类似物的PET成像：前景与陷阱。 - Suppr

Suppr

超能文献

PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls.

作者信息

Shields Anthony F

机构信息

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.

出版信息

J Nucl Med. 2003 Sep;44(9):1432-4.

PMID:12960188

Abstract

摘要

相似文献

PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls.

J Nucl Med. 2003 Sep;44(9):1432-4.

Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfalls.

PET Clin. 2014 Jul;9(3):331-8. doi: 10.1016/j.cpet.2014.03.005. Epub 2014 Apr 26.

Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?

J Nucl Med. 2004 Oct;45(10):1677-82.

Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.

J Nucl Med. 2005 Feb;46(2):371-80.

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

J Nucl Med. 2003 Dec;44(12):2027-32.

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

Cancer Res. 2003 Jul 1;63(13):3791-8.

Molecular imaging in animal models of disease--every little detail counts!

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):899-900. doi: 10.1007/s00259-005-1857-1.

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

J Nucl Med. 2003 Sep;44(9):1426-31.

3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?

J Nucl Med. 2003 Dec;44(12):1927-32.

Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.

J Nucl Med. 2005 Feb;46(2):274-82.

引用本文的文献

Landscape of targets within nucleoside metabolism for the modification of immune responses.

Front Oncol. 2025 May 30;15:1483769. doi: 10.3389/fonc.2025.1483769. eCollection 2025.

Nuclear Medicine Imaging Techniques in Glioblastomas.

Neurochem Res. 2024 Nov;49(11):3006-3013. doi: 10.1007/s11064-024-04233-6. Epub 2024 Sep 5.

Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study.

Ann Transl Med. 2022 Nov;10(22):1196. doi: 10.21037/atm-20-5214.

Potential novel imaging targets of inflammation in cardiac sarcoidosis.

J Nucl Cardiol. 2022 Oct;29(5):2171-2187. doi: 10.1007/s12350-021-02838-w. Epub 2021 Nov 3.

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.

Oncologist. 2020 Aug;25(8):e1158-e1169. doi: 10.1634/theoncologist.2020-0039. Epub 2020 Jun 17.

Evaluation of genotoxic potential of peptides used in nuclear medicine (PSMA -617 and -11, and ubiquicidine 29-41) using a flow-cytometric, semi-automated analysis of micronuclei frequency in cell cultures.

Toxicol Rep. 2020 Feb 7;7:304-316. doi: 10.1016/j.toxrep.2020.02.003. eCollection 2020.

Approaches to PET Imaging of Glioblastoma.

Molecules. 2020 Jan 28;25(3):568. doi: 10.3390/molecules25030568.

Intratumoral F-FLT infusion in metabolic targeted radiotherapy.

EJNMMI Res. 2019 Apr 11;9(1):33. doi: 10.1186/s13550-019-0496-7.

Preliminary F-MRS Study of Tumor Cell Proliferation with 3'-deoxy-3'-fluorothymidine and Its Metabolite (FLT-MP).

Contrast Media Mol Imaging. 2017 Sep 26;2017:3981358. doi: 10.1155/2017/3981358. eCollection 2017.

Optical imaging probes in oncology.

Oncotarget. 2016 Jul 26;7(30):48753-48787. doi: 10.18632/oncotarget.9066.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验